GeneDx Corp. (WGS)
NASDAQ: WGS
· Real-Time Price · USD
67.12
4.80 (7.70%)
At close: May 02, 2025, 3:59 PM
65.92
-1.79%
After-hours: May 02, 2025, 04:13 PM EDT
Company Description
GeneDx Holdings Corp. is a patient centered health intelligence company.
It engages in transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories.
The firm, through its Centrellis health intelligence platform, generates a more complete understanding of disease and wellness and provides science-driven solutions to the most pressing medical needs.
The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, CT.
GeneDx Corp.
| Country | United States |
| IPO Date | Nov 4, 2020 |
| Industry | Medical - Healthcare Information Services |
| Sector | Healthcare |
| Employees | 1,000 |
| CEO | Katherine A. Stueland |
Contact Details
Address: North Tower Stamford, Connecticut United States | |
| Website | http://www.genedx.com |
Stock Details
| Ticker Symbol | WGS |
| Exchange | NASDAQ |
| Fiscal Year | n/a |
| Reporting Currency | USD |
| CIK Code | 0001818331 |
| CUSIP Number | 81663L200 |
| ISIN Number | US81663L2007 |
| Employer ID | 85-1966622 |
| SIC Code | 8000 |
Key Executives
| Name | Position |
|---|---|
| Katherine A. Stueland | President, Chief Executive Officer & Director |
| Dr. Bryan M. Dechairo Ph.D. | Chief Operating Officer |
| Heidi C. Chen J.D. | Chief Legal Officer |
| Kevin Feeley CPA | Chief Financial Officer |
| Eric Olivares Ph.D. | Chief Product & Technology Officer |
| Jami Biliboaca | Head of People Strategy |
| Melanie Duquette | Chief Growth Officer |
| Paul Kruszka FACMG, M.D., M.P.H. | Chief Medical Officer |
| Sabrina Dunbar | Chief of Staff |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 01, 2025 | 4 | Filing |
| May 01, 2025 | 4 | Filing |
| Apr 30, 2025 | ARS | Filing |
| Apr 30, 2025 | DEFA14A | Filing |
| Apr 30, 2025 | DEF 14A | Filing |
| Apr 30, 2025 | 10-Q | Quarterly Report |
| Apr 30, 2025 | 8-K | Current Report |
| Apr 16, 2025 | 8-K | Current Report |
| Apr 10, 2025 | 4 | Filing |
| Apr 10, 2025 | 4 | Filing |